Lsv Asset Management United Therapeutics Corp Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

A detailed history of Lsv Asset Management transactions in United Therapeutics Corp stock. As of the latest transaction made, Lsv Asset Management holds 969,465 shares of UTHR stock, worth $358 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

969,465

Previous 966,370 0.32%

Holding current value

$358 Million

Previous $308 Million 12.85%

% of portfolio

0.74%

Previous 0.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$311.04 - $363.55 $962,668 - $1.13 Million	3,095 Added 0.32%	969,465 $347 Million
Q2 2024 Aug 06, 2024	BUY	$228.26 - $319.04 $99.7 Million - $139 Million	436,851 Added 82.5%	966,370 $308 Million
Q1 2024 May 06, 2024	BUY	$210.76 - $249.51 $32.1 Million - $38 Million	152,151 Added 40.32%	529,519 $122 Million
Q4 2023 Feb 06, 2024	SELL	$214.88 - $256.94 $1.22 Million - $1.46 Million	-5,700 Reduced 1.49%	377,368 $83 Million
Q3 2023 Nov 03, 2023	BUY	$211.82 - $248.24 $783,734 - $918,488	3,700 Added 0.98%	383,068 $86.5 Million
Q2 2023 Aug 02, 2023	SELL	$205.19 - $232.99 $3.87 Million - $4.39 Million	-18,840 Reduced 4.73%	379,368 $83.7 Million
Q1 2023 May 02, 2023	SELL	$212.99 - $276.17 $2.94 Million - $3.81 Million	-13,810 Reduced 3.35%	398,208 $89.2 Million
Q4 2022 Feb 08, 2023	SELL	$205.95 - $280.43 $31.6 Million - $43 Million	-153,504 Reduced 27.14%	412,018 $115 Million
Q3 2022 Nov 07, 2022	SELL	$203.3 - $244.17 $5.27 Million - $6.32 Million	-25,900 Reduced 4.38%	565,522 $118 Million
Q2 2022 Aug 10, 2022	SELL	$174.81 - $241.14 $520,933 - $718,597	-2,980 Reduced 0.5%	591,422 $139 Million
Q1 2022 May 12, 2022	BUY	$166.16 - $213.96 $9.53 Million - $12.3 Million	57,350 Added 10.68%	594,402 $107 Million
Q4 2021 Jan 28, 2022	BUY	$184.32 - $216.08 $2.35 Million - $2.76 Million	12,766 Added 2.43%	537,052 $116 Million
Q3 2021 Nov 04, 2021	SELL	$179.86 - $214.88 $5.28 Million - $6.3 Million	-29,340 Reduced 5.3%	524,286 $96.8 Million
Q2 2021 Aug 04, 2021	SELL	$170.47 - $211.93 $3.37 Million - $4.19 Million	-19,770 Reduced 3.45%	553,626 $99.3 Million
Q1 2021 Apr 30, 2021	SELL	$153.94 - $174.85 $3.91 Million - $4.44 Million	-25,420 Reduced 4.25%	573,396 $95.9 Million
Q4 2020 Feb 08, 2021	BUY	$101.87 - $151.79 $4.16 Million - $6.2 Million	40,860 Added 7.32%	598,816 $90.9 Million
Q3 2020 Oct 23, 2020	BUY	$99.9 - $121.13 $3.99 Million - $4.84 Million	39,922 Added 7.71%	557,956 $56.4 Million
Q2 2020 Aug 05, 2020	BUY	$92.74 - $125.82 $16.3 Million - $22.1 Million	175,287 Added 51.14%	518,034 $62.7 Million
Q1 2020 May 07, 2020	BUY	$79.39 - $115.35 $11.6 Million - $16.9 Million	146,354 Added 74.52%	342,747 $32.5 Million
Q4 2019 Feb 10, 2020	BUY	$78.31 - $95.34 $5.29 Million - $6.44 Million	67,534 Added 52.41%	196,393 $17.3 Million
Q3 2019 Nov 07, 2019	SELL	$74.85 - $85.99 $6.35 Million - $7.3 Million	-84,893 Reduced 39.72%	128,859 $10.3 Million
Q2 2019 Aug 08, 2019	SELL	$76.06 - $120.81 $24.1 Million - $38.4 Million	-317,463 Reduced 59.76%	213,752 $16.7 Million
Q1 2019 May 07, 2019	SELL	$107.15 - $126.84 $9.14 Million - $10.8 Million	-85,334 Reduced 13.84%	531,215 $62.3 Million
Q4 2018 Feb 05, 2019	BUY	$101.4 - $128.73 $10.8 Million - $13.7 Million	106,460 Added 20.87%	616,549 $67.1 Million
Q3 2018 Nov 06, 2018	BUY	$113.81 - $129.46 $3.37 Million - $3.83 Million	29,600 Added 6.16%	510,089 $65.2 Million
Q2 2018 Aug 08, 2018	BUY	$101.14 - $118.31 $6.08 Million - $7.12 Million	60,149 Added 14.31%	480,489 $54.4 Million
Q1 2018 May 04, 2018	BUY	$107.21 - $151.94 $15.7 Million - $22.2 Million	146,194 Added 53.33%	420,340 $47.2 Million
Q4 2017 Feb 01, 2018	BUY	$118.58 - $151.28 $12.2 Million - $15.5 Million	102,565 Added 59.78%	274,146 $0
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $19.7 Million - $23.5 Million	171,581	171,581 $20.1 Million

Others Institutions Holding UTHR

# of Institutions

672

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.8B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management United Therapeutics Corp Transaction History